I Want To...
I Want To...
Find Research Faculty
Enter the last name, specialty or keyword for your search below.
School of Medicine
Akrit Singh Sodhi, M.D., Ph.D.
Associate Professor of Ophthalmology
Languages: English, Spanish
Expertise: Diabetic Macular Edema, Diabetic Retinopathy, Epiretinal Membranes, Macular Degeneration (Age-Related), Macular Holes, Macular Puckers, Medical Diseases of the Retina, Ophthalmology, Proliferative Vitreoretinopathy, Retinal Detachment, Retinal Vein Occlusion, Surgical Diseases of the Retina, Vitreoretinal Diseases and Surgery Service ...read more
Research Interests: ocular tumors; pathological angiogenesis
Request an Appointment
I live in Maryland
Request an appointment through My
I live outside of Maryland
I live outside of the United States
The Johns Hopkins Hospital
Appointment Phone: 410-955-3518
600 N. Wolfe Street
Wilmer Eye Institute
Baltimore, MD 21287 map
Johns Hopkins Wilmer Eye Institute - Columbia
Appointment Phone: 410-910-2330
10710 Charter Drive
Medical Pavilion at Howard County, Suite 310
Columbia, MD 21044 map
Akrit Sodhi, M.D, Ph.D., is an assistant professor of ophthalmology at the Wilmer Eye Institute. He specializes in the medical and surgical management of vitreoretinal diseases.
Dr. Sodhi obtained his M.D. and Ph.D. degrees from the University of California at Davis. He interned at Sinai Hospital in Baltimore and completed his ophthalmology residency training at the Wilmer Eye Institute at Johns Hopkins in 2008, followed by a fellowship in retina at Wilmer while also serving as chief resident. He joined the Wilmer faculty in 2010. Dr. Sodhi’s research interests, currently sponsored by a grant from the National Eye Institute, include the examination of the role of hypoxia inducible factor (HIF) in ocular disease.
- Associate Professor of Ophthalmology
- MD, University of California Davis School of Medicine (2001)
- Johns Hopkins University School of Medicine / Ophthalmology (2008)
- American Board of Ophthalmology / Ophthalmology (2009)
Research & Publications
Identification of novel diagnostic markers and therapeutic targets that lead to new and more effective treatments for retinal and choroidal vascular diseases, including diabetic eye disease, age-related macular degeneration, retinal vein occlusions, sickle cell retinopathy, congenital retinal vascular diseases (e.g., Coats Disease), and intraocular tumors (e.g., von Hippel-Lindau hemangioblastoma and uveal melanoma).